US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NVIDIA Portfolio

3,190.34

+55.191.76%

Number of Gainers:6

Number of Losers:2

Number of Flat:- -

PE:- -

High:3,243.92

Open:3,146.13

Low:3,146.13

Close:3,135.15

Volume:115.47M

Turnover:2.58B

Market Cap:183.58B

Float Cap:52.08B

Loading ...

Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX) and Penumbra (PEN)

Polymarket Odds: Will RKLB, SOUN, CELH Beat Earnings Tomorrow?

Market Chatter: Commerce Department to Hold Meeting With US Robotics Companies on Competition With China

MT Newswires Live

Commerce Department to Hold Meeting With US Robotics Companies on Competition With China, Semafor Reports

MT Newswires Live

SoundHound Stock Is Climbing Wednesday: What's Driving The Action?

Benzinga_recent_news

What's Behind The Jump In Recursion Pharmaceuticals Stock?

Assessing Serve Robotics (SERV) Valuation After Recent Share Price Volatility

Simply Wall St.

SoundHound AI Inc - Bengaluru Hub to Advance SoundHound's Agentic AI Platform

THOMSON REUTERS

SoundHound AI Opens New Innovation Hub in Bengaluru, India

U.S. Mortgage Rates Hit Near Four-Year Low, Yet Homebuyers Remain Hesitant

Serve Robotics Inc. Updates Financial Calendar

Recursion Pharmaceuticals Q4 Loss Narrows, Revenue Rises

MT Newswires Live

Recursion Pharmaceuticals Inc - May Sell Class a Stock up to $300 Mln - SEC Filing

THOMSON REUTERS

Recursion Pharma Q4 revenue tops eatimates, helped by Sanofi payments

Recursion's 2025 Cash Balance Was $753.9M With Expected Cash Runway Extending Into Early 2028

Earnings Flash (RXRX)Recursion Pharmaceuticals Posts Q4 Loss $0.21 a Share, vs. FactSet Est of $0.21 Loss

MT Newswires Live

Recursion Pharmaceuticals Q4 2025 EPS $(0.21) Beats $(0.27) Estimate, Sales $35.537M Beat $24.586M Estimate

BRIEF-Recursion Pharmaceuticals Q4 Operating Revenue USD 35.351 Million Vs. IBES Estimate USD 24.6 Million

Recursion Q4 revenue hits USD 35.5 million, up 7.8x

Recursion Pharmaceuticals Q4 Pretax Profit USD -108.104 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4609/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4609","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","market":"US","secType":"PLATE","nameCN":"NVIDIA Portfolio","latestPrice":3190.3384,"timestamp":1772053199999,"preClose":3135.1492,"halted":0,"volume":115467327,"delay":0,"changeRate":0.017603,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":55.189209,"latestTime":"02-25 16:00:00 EST","open":3146.1306,"high":3243.9202,"low":3146.1306,"amount":2575423663.435411,"amplitude":0.031191,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772067600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":10.433707,"peRate":-274.830783,"turnoverRate":0.068613,"increases":6,"decrements":2,"flats":0,"marketCap":183575487232,"floatMarketCap":52078556432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","high":3243.9202,"amplitude":0.031191,"preClose":3135.1492,"low":3146.1306,"pbRate":"10.433707","latestPrice":3190.3384,"volume":115467327,"delay":0,"open":3146.1306,"prevYearClose":2748.3132,"prevWeekClose":3013.6343,"prevMonthClose":2841.0637,"prevQuarterClose":2748.3132,"fiveDayClose":3116.7104,"twentyDayClose":3251.7473,"sixtyDayClose":3115.479,"secType":"PLATE","market":"US","turnoverRate":0.068613,"peRate":-274.830783,"marketCap":183575487232,"floatMarketCap":52078556432,"timestamp":1772053199999,"nameCN":"NVIDIA Portfolio"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4609\",,,,undefined,":{"bkCode":"BK4609","up":6,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4609\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614805310","title":"Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX) and Penumbra (PEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614805310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614805310?lang=en_us&edition=fundamental","pubTime":"2026-02-26 04:00","pubTimestamp":1772049624,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Recursion Pharmaceuticals (RXRX – Research Report) and Penumbra (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-recursion-pharmaceuticals-rxrx-and-penumbra-pen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-recursion-pharmaceuticals-rxrx-and-penumbra-pen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4082","BK4581","BK4609","LU0128526141.USD","BK4539","BK4585","BK4139","LU0029874061.USD","XBI","BK4588","LABU","PEN","BK4611","RXRX","BK4548"],"gpt_icon":0},{"id":"2614795058","title":"Polymarket Odds: Will RKLB, SOUN, CELH Beat Earnings Tomorrow?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614795058","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614795058?lang=en_us&edition=fundamental","pubTime":"2026-02-26 03:20","pubTimestamp":1772047241,"startTime":"0","endTime":"0","summary":"On Thursday, February 26, Rocket Lab ($RKLB), SoundHound ($SOUN), and Celsius ($CELH) will report their earnings for the period ended December 31. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/polymarket-odds-will-rklb-soun-celh-beat-earnings-tomorrow?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/polymarket-odds-will-rklb-soun-celh-beat-earnings-tomorrow?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4177","RKLZ","LU2211815571.USD","RKLX","BK4547","BK4585","SOUX","BK4587","LU2543165471.USD","BK4588","BK4187","LU2065731478.USD","BK4609","LU2211817866.USD","BK4613","SOUN","BK4023","RKLB","BK4564","CELH","BK4608"],"gpt_icon":0},{"id":"2614977058","title":"Market Chatter: Commerce Department to Hold Meeting With US Robotics Companies on Competition With China","url":"https://stock-news.laohu8.com/highlight/detail?id=2614977058","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614977058?lang=en_us&edition=fundamental","pubTime":"2026-02-26 03:14","pubTimestamp":1772046893,"startTime":"0","endTime":"0","summary":"The US Department of Commerce is holding a meeting on March 10 with American robot manufacturers to discuss ways to boost the industry in the US and thwart competition from China, Semafor reported Wednesday, citing an invitation from the agency's National Telecommunications and Information Administration it reviewed.Price: 57.68, Change: +1.38, Percent Change: +2.44","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","RR","SERV","BK4209","BK4609","BOTZ","BK4604","BK4161","BK4588"],"gpt_icon":0},{"id":"2614586350","title":"Commerce Department to Hold Meeting With US Robotics Companies on Competition With China, Semafor Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2614586350","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614586350?lang=en_us&edition=fundamental","pubTime":"2026-02-26 03:09","pubTimestamp":1772046550,"startTime":"0","endTime":"0","summary":"Price: 57.12, Change: +0.82, Percent Change: +1.45","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4209","BK4161","BK4588","BK4585","BK4604","BK4609"],"gpt_icon":0},{"id":"2614392160","title":"SoundHound Stock Is Climbing Wednesday: What's Driving The Action?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614392160","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614392160?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:58","pubTimestamp":1772035080,"startTime":"0","endTime":"0","summary":"SoundHound AI Inc (NASDAQ:SOUN) shares are up on Wednesday following the announcement of a new voice-powered retail tool aimed at enhancing customer interactions.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/25/Porto--Portugal---October-25th--2024-Sou.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/25/Porto--Portugal---October-25th--2024-Sou.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50855073/soundhound-stock-is-climbing-thursday-whats-driving-the-action","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50855073/soundhound-stock-is-climbing-thursday-whats-driving-the-action","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["AIYY","BK4547","AI","BK4587","SOUN","BK4585","BK4588","BK4528","BK4609","SOUX","BK4023","BK4608","BK4543","BK4551","BK4613"],"gpt_icon":1},{"id":"2614303929","title":"What's Behind The Jump In Recursion Pharmaceuticals Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614303929","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614303929?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:54","pubTimestamp":1772034840,"startTime":"0","endTime":"0","summary":"Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) are surging Wednesday following a robust earnings report released before the bell.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/25/Closse-up-Shot-Of-White-Pills-On-Conveyo.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/25/Closse-up-Shot-Of-White-Pills-On-Conveyo.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50854848/whats-behind-the-jump-in-recursion-pharmaceuticals-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50854848/whats-behind-the-jump-in-recursion-pharmaceuticals-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4548","BK4611","RXRX","BK4609","BK4539","BK4139"],"gpt_icon":1},{"id":"2614039629","title":"Assessing Serve Robotics (SERV) Valuation After Recent Share Price Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2614039629","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614039629?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:34","pubTimestamp":1772033643,"startTime":"0","endTime":"0","summary":"Serve Robotics stock performance catches attention\nServe Robotics (SERV) has drawn fresh investor attention after recent trading, with the stock last closing at US$9.67. Short term returns are mixed, with a 4.7% move over the past day and a 4.3% gain over the past week.\nOver the past month the share price shows a 24.1% decline, while the past 3 months reflect a 4.3% negative total return and the year to date move stands at an 18.3% decline. Over the past year, Serve Robotics has a 1.7%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4214000-choice2-main-header/1585186565403","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4214000-choice2-main-header/1585186565403"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-services/nasdaq-serv/serve-robotics/news/assessing-serve-robotics-serv-valuation-after-recent-share-p-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-services/nasdaq-serv/serve-robotics/news/assessing-serve-robotics-serv-valuation-after-recent-share-p-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4609","BK4604","BK4209","SERV"],"gpt_icon":0},{"id":"2614223038","title":"SoundHound AI Inc - Bengaluru Hub to Advance SoundHound's Agentic AI Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2614223038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614223038?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:09","pubTimestamp":1772028585,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL127:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4608","BK4613","SOUN","BK4023","BK4587","SOUX","BK4609","BK4547"],"gpt_icon":0},{"id":"2614038982","title":"SoundHound AI Opens New Innovation Hub in Bengaluru, India","url":"https://stock-news.laohu8.com/highlight/detail?id=2614038982","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614038982?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:03","pubTimestamp":1772028199,"startTime":"0","endTime":"0","summary":"SoundHound AI Inc. has opened a new innovation hub in Bengaluru, India, to accelerate its global expansion in agentic AI. The company said the site will serve as a key center for advancing its next-generation agentic AI platform and scaling enterprise voice and conversational AI solutions across industries.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL2wt8sb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","BK4608","LU2095319765.USD","BK4609","SOUX","IE00B3QW5Z07.USD","SOUN","SG9999014039.USD","BK4547","BK4112","SG9999014021.USD","SG9999014013.SGD","LU2210150020.SGD","BK4587","IE00BKPKM429.USD","BK4613","BK4588","SG9999014005.SGD","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","BK4023"],"gpt_icon":1},{"id":"1141735133","title":"U.S. Mortgage Rates Hit Near Four-Year Low, Yet Homebuyers Remain Hesitant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141735133","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141735133?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:31","pubTimestamp":1772026300,"startTime":"0","endTime":"0","summary":"Last week saw a significant drop in U.S. mortgage rates. While this has helped sustain the momentum in refinancing growth, it does not appear to have stimulated home purchase demand. According to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","ARMG","BK4141","IYR","LU0348723411.USD","LU2543165471.USD","BK4585","ARMW","BK4609","FNMA","IE00BMPRXN33.USD","LU0081259029.USD","REM","BK4588","ARMU","IE00BMPRXQ63.HKD","IE00BMPRXR70.SGD"],"gpt_icon":0},{"id":"2614084539","title":"Serve Robotics Inc. Updates Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2614084539","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614084539?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:30","pubTimestamp":1772022626,"startTime":"0","endTime":"0","summary":"Serve Robotics Inc. Updates Financial Calendar               Serve Robotics Inc. will report its 2025 fourth quarter financial results before the opening of regular trading on March 11, 2026, and will","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL1zXpbL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","LU0314104364.USD","NDAQ","SERV","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4588","SG9999014021.USD","LU2095319765.USD","SG9999014039.USD","BK4604","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014013.SGD","BK4209","IE00BKPKM429.USD","LU2210150020.SGD","BK4585","BK4112"],"gpt_icon":0},{"id":"2614808951","title":"Recursion Pharmaceuticals Q4 Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2614808951","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614808951?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:54","pubTimestamp":1772020454,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  reported a Q4 loss Wednesday of $0.21 per diluted share, narrowing from a loss of $0.53 a year earlier.Analysts polled by FactSet expected a loss of $0.31.Revenue for the quarter ended Dec. 31 was $35.5 million, up from $4.5 million a year earlier.Analysts surveyed by FactSet expected $24.5 million.As of Dec. 31, Recursion said it had $753.9 million in cash and cash equivalents, which it expects to provide it with a cash runway through early 2028.Shares of the company were up more than 12% in recent Wednesday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","RXRX","BK4609","BK4611","BK4139","BK4548"],"gpt_icon":1},{"id":"2614089881","title":"Recursion Pharmaceuticals Inc - May Sell Class a Stock up to $300 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614089881","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614089881?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:46","pubTimestamp":1772020019,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL0LU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4609","BK4139","RXRX","BK4539","BK4611","BK4548"],"gpt_icon":0},{"id":"2614108608","title":"Recursion Pharma Q4 revenue tops eatimates, helped by Sanofi payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2614108608","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614108608?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:44","pubTimestamp":1772019858,"startTime":"0","endTime":"0","summary":"Recursion Pharma Q4 revenue tops eatimates, helped by Sanofi paymentsOverviewClinical stage TechBio firm's Q4 operating revenue beat analyst expectationsNet income for Q4 exceeded analyst estimatesCom","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL1N3ZL0GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4609","RXRX","BK4539","BK4548","BK4139"],"gpt_icon":1},{"id":"2614086139","title":"Recursion's 2025 Cash Balance Was $753.9M With Expected Cash Runway Extending Into Early 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2614086139","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614086139?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:37","pubTimestamp":1772019448,"startTime":"0","endTime":"0","summary":"Recursion's 2025 Cash Balance Was $753.9M With Expected Cash Runway Extending Into Early 2028","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50843855/recursions-2025-cash-balance-was-753-9m-with-expected-cash-runway-extending-into-early-2028","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4139","BK4611","BK4609","BK4539","BK4548"],"gpt_icon":0},{"id":"2614086196","title":"Earnings Flash (RXRX)Recursion Pharmaceuticals Posts Q4 Loss $0.21 a Share, vs. FactSet Est of $0.21 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2614086196","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614086196?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:37","pubTimestamp":1772019435,"startTime":"0","endTime":"0","summary":"Earnings Flash (RXRX)Recursion Pharmaceuticals Posts Q4 Loss $0.21 a Share, vs. FactSet Est of $0.21 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4609","BK4539","BK4548","RXRX","BK4611"],"gpt_icon":0},{"id":"2614908657","title":"Recursion Pharmaceuticals Q4 2025 EPS $(0.21) Beats $(0.27) Estimate, Sales $35.537M Beat $24.586M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2614908657","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614908657?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:32","pubTimestamp":1772019121,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals Q4 2025 EPS $(0.21) Beats $(0.27) Estimate, Sales $35.537M Beat $24.586M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50843522/recursion-pharmaceuticals-q4-2025-eps-0-21-beats-0-27-estimate-sales-35-537m-beat-24-586m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","RXRX","BK4539","BK4548","BK4609","BK4139"],"gpt_icon":0},{"id":"2614108668","title":"BRIEF-Recursion Pharmaceuticals Q4 Operating Revenue USD 35.351 Million Vs. IBES Estimate USD 24.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614108668","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614108668?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:30","pubTimestamp":1772019046,"startTime":"0","endTime":"0","summary":"Feb 25  - Recursion Pharmaceuticals Q4 operating income USD -108.335 million.Q4 net income USD -108.124 million vs. IBES estimate USD -131.1 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nPLXAB03CD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4539","BK4139","BK4609","RXRX","BK4548"],"gpt_icon":0},{"id":"2614086635","title":"Recursion Q4 revenue hits USD 35.5 million, up 7.8x","url":"https://stock-news.laohu8.com/highlight/detail?id=2614086635","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614086635?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:30","pubTimestamp":1772019040,"startTime":"0","endTime":"0","summary":"Recursion reported Q4 2025 total revenue of USD 35.5 million  and FY 2025 total revenue of USD 74.7 million . Q4 2025 net loss was USD 108.1 million, and FY 2025 net loss was USD 644.8 million. Cash, cash equivalents and restricted cash totaled USD 753.9 million at Dec. 31, 2025, with Recursion stating its expected cash runway extends into early 2028; FY 2025 net cash used in operating activities was USD 371.8 million and FY 2025 cash operating expense  was USD 399.2 million. On business updates, Recursion highlighted positive preliminary Phase 2 results for REC-4881 in familial adenomatous polyposis , including 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks , with 82% maintaining durable reductions after 12 weeks off therapy and a 53% median reduction from baseline. The company also said it achieved a fifth Sanofi milestone in February 2026 for a USD 4 million payment, bringing total payments received from the Sanofi partne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL1yK68Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00B64PRP62.GBP","BK4588","BK4585","BK4539","LU0314104364.USD","BK4609","BK4139","IE00BKPKM429.USD","LU2210150020.SGD","IE00BGHQF748.EUR","BK4112","SG9999014005.SGD","SG9999014039.USD","BK4611","LU2095319765.USD","LU2210149790.SGD","RXRX","BK4548","IE00B3QW5Z07.USD","SG9999014021.USD"],"gpt_icon":1},{"id":"2614871086","title":"Recursion Pharmaceuticals Q4 Pretax Profit USD -108.104 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614871086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614871086?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:30","pubTimestamp":1772019001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nPLXAB03CD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","BK4139","BK4609","BK4548","BK4539","BK4611"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":133,"code":"91000000","status":"200"}]}}